Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial

Efficacy of combining intravitreal injections of ranibizumab with micropulse diode laser versus intravitreal injections of ranibizumab alone in diabetic macular edema (ReCaLL): a single center, randomised, controlled, non-inferiority clinical trial

Abstract Background To evaluate if a combination therapy with micropulse diode laser (MPL) shows non-inferiority on visual acuity (BCVA) within 12 months in comparison to standard therapy, i.e. intravitreal injection of ranibizumab alone. Setting Institutional. Prospective randomized single-center t...

Full description

Bibliographic Details
Main Authors: Olga Furashova, Patrick Strassburger, Klio Ai Becker, Katrin Engelmann
Format: Article
Language:English
Published: BMC 2020-07-01
Series:BMC Ophthalmology
Subjects:
Diabetic macular edema
Ranibizumab
VEGF inhibitor
Intravitreal injection
Micropulse diode laser
Online Access:http://link.springer.com/article/10.1186/s12886-020-01576-w

Internet

http://link.springer.com/article/10.1186/s12886-020-01576-w

Similar Items